Identifying molecular features of cancers that predict response to anti-cancer drugs.

Browse our data

Our website and results are part of an ongoing research project. These webpages are updated frequently and our results are not final or complete.


e.g. Docetaxel, RP-56976, BRAF, COLO-829

What's new!

  • Release 6 (July 2016)
  • A major upgrade to the GDSC website including new large-scale drug screening datasets and new 'pan-cancer' and 'cancer-specific' analyses.

Mailing List

To receive news and data release alert, please sign up Translation-announce

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Trust Sanger Institute.